ATI RN · Physical Assessment · physical examination and health assessment test bank

Option D: Overflow incontinence is best treated using alpha-adrenergic antagonists, as these medications help relax the bladder neck and prostate, improving urine flow and reducing retention. This is particularly effective in cases where bladder outlet obstruction is present, allowing for better management of symptoms and improved quality of life.

Option A: Functional incontinence is primarily managed through behavioral interventions and bladder training rather than pharmacological agents like alpha-adrenergic antagonists, which do not address the underlying functional issues.

Option B: Renal insufficiency requires careful management of fluid and electrolyte balance, and alpha-adrenergic antagonists do not directly treat the underlying renal pathology or improve kidney function.

Option C: Urge incontinence is typically treated with anticholinergic medications or beta-3 agonists, which target the overactive bladder muscle, making alpha-adrenergic antagonists unsuitable for this condition.

Takeaways: Alpha-adrenergic antagonists are effective for treating overflow incontinence due to their role in relaxing the bladder neck and improving urine flow, which is crucial for managing urinary retention and bladder outlet obstruction effectively.

Option B: Phenazopyridine (Pyridium) is recommended for very short-term use in patients with urinary tract infections (UTIs) primarily due to the potential occurrence of hemolytic anemia, especially in patients with glucose-6-phosphate dehydrogenase (G6PD) deficiency. This adverse effect necessitates careful consideration of its duration of use to mitigate risks associated with prolonged therapy.

Option A: Possible resistance does not apply to phenazopyridine, as it is not an antibiotic and does not contribute to the development of bacterial resistance. Its role is solely as a urinary analgesic.

Option C: Gastritis is not a common concern associated with phenazopyridine. While gastrointestinal side effects can occur, they are not the primary reason for limiting its use in UTIs.

Option D: Cost is not a primary factor in the recommendation for short-term use of phenazopyridine. The focus is on safety and the potential for serious side effects rather than financial considerations.

Takeaways: Understanding the risks associated with medications like phenazopyridine, particularly the potential for hemolytic anemia in susceptible individuals is crucial for safe prescribing practices in the management of urinary tract infections.

Option C: Vaginal discharge is a hallmark symptom of trichomoniasis, often characterized by a frothy, yellow-green discharge with a strong odor. This symptom is commonly reported by patients and is a key indicator for diagnosis and treatment.

Option A: A painless, ulcerated vulvar lesion with vaginal discharge is more indicative of other conditions such as herpes or syphilis, rather than trichomoniasis.

Option B: Fever, papules, and vaginal discharge with burning are not typical presentations of trichomoniasis, as this infection usually does not cause systemic symptoms like fever.

Option D: Dyspareunia and upper abdominal pain are not specific to trichomoniasis and can occur in various other gynecological conditions, making them less relevant as chief complaints for this diagnosis.

Takeaways: Understanding that vaginal discharge is a common chief complaint in trichomoniasis helps in accurate diagnosis and treatment, as it requires appropriate management and patient education to address the infection effectively.

Option B: Order a thyroid function test and ultrasound is the most appropriate action when an enlarged thyroid is noted, as it allows for the assessment of thyroid hormone levels and the identification of any structural abnormalities. This is essential for determining the underlying cause of the enlargement and guiding further management.

Option A: Documenting the finding and observing for a few weeks does not address the need for immediate evaluation of thyroid function and potential pathology, which could lead to delayed diagnosis and treatment.

Option C: Advising the patient to take iodine supplements may not be appropriate without knowing the cause of the enlargement, as excess iodine can exacerbate certain thyroid conditions, such as autoimmune thyroiditis.

Option D: Scheduling a follow-up appointment in six months neglects the urgency of evaluating the thyroid enlargement, which could indicate serious underlying conditions that require timely intervention.

Takeaways: Evaluating an enlarged thyroid requires prompt action, including ordering thyroid function tests and imaging to determine the cause and appropriate management, rather than delaying or assuming treatment without assessment.

Option A: Buspirone (Buspar) is indicated for patients with generalized anxiety disorder as it is an anxiolytic that works by affecting serotonin and dopamine receptors, providing relief from anxiety symptoms without the sedative effects commonly associated with other anxiolytics.

Option B: Citalopram (Celexa) is an SSRI primarily used for depression and may be used off-label for anxiety, but it is not the first-line treatment specifically indicated for generalized anxiety disorder.

Option C: Imipramine (Tofranil) is a tricyclic antidepressant that can be effective for anxiety but is not typically the first choice for generalized anxiety disorder due to its side effect profile and the availability of more effective options.

Option D: Bupropion HCL (Wellbutrin) is primarily an antidepressant and is not indicated for anxiety disorders; it can sometimes exacerbate anxiety symptoms in susceptible individuals.

Takeaways: Buspirone is a first-line treatment for generalized anxiety disorder due to its unique mechanism of action, which requires patient education about its effects and proper usage to ensure optimal therapeutic outcomes.